Baltimore, MD, United States of America

Shirley H Purvis

This inventor holds 2 USPTO granted patents and 2 published patent applications. Top assignee: Johns Hopkins University. Active years: 2019-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Shirley H Purvis. Retrieved from https://idiyas.com/inventor/shirley-h-purvis

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2019-2022

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by Shirley H. Purvis

Introduction

Shirley H. Purvis is a notable inventor based in Baltimore, MD (US). He has made significant contributions to the field of medical research, particularly in the treatment of sickle cell disease. With a total of 2 patents, his work has the potential to impact many lives.

Latest Patents

One of his latest patents focuses on "Aptamers for the treatment of sickle cell disease." This invention provides polynucleotide aptamers that selectively bind to and inhibit the polymerization of sickle hemoglobin (HbS). The patent includes pharmaceutical compositions comprising these aptamers, methods of use for diagnostics and treatment of sickle cell disease, methods of use as capture reagents, and methods of rational drug design.

Career Highlights

Shirley H. Purvis is affiliated with Johns Hopkins University, where he continues to advance his research and innovations. His work is recognized for its potential to improve therapeutic strategies for patients suffering from sickle cell disease.

Collaborations

He has collaborated with notable colleagues, including James Francis Casella and Emily Barron-Casella, who contribute to the research environment at Johns Hopkins University.

Conclusion

Shirley H. Purvis exemplifies the spirit of innovation in medical research, particularly through his work on aptamers for sickle cell disease. His contributions are paving the way for new treatment options and improving patient outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…